Mohammed R. Mhawish Named 2025 Recipient of the Neal Conan Prize for Excellence in Journalism
NEW YORK, Dec. 3, 2025 /PRNewswire/ -- The Neal Conan Prize for Excellence in Journalism has named Mohammed R. Mhawish as the 2025 winner of its annual $50,000 award, following a presentation ceremony held on November 22 in New York City. The Prize...
A NEW HOPE FOR PATIENTS SUFFERING FROM POTENTIALLY FATAL RARE HEART DISEASE: NUHCS IS FIRST IN ASIA TO RECRUIT PATIENTS FOR LANDMARK GENE EDITING CLINICAL TRIAL
The international study explores gene editing therapy to stop the production of proteins causing the disease in ATTR-CM patients SINGAPORE, May 14, 2025 /PRNewswire/ -- While receiving treatment for a car accident ten years ago, Mr Chua learnt that...
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...